Prof. Paul de Souza in Case study one paints a picture of a man not in remission in July to Oct 2014. "Significant pain increase, opioids commenced ◦ PSA 140 ◦ Significant destructive Mass involving T11, R pelvic nodes increased in size (largest 6cm)" Oct 2014: Palliative RT approach for pain management" http://www.noxopharm.com/irm/PDF/1522_1/TROGAnnualScientificMeetingNoxopharmPresentation21318.
Three blood test in the clear puts that patient in remission at April 2015.
GK leaves NRT three months latter.
Noxopharm prospectus June 2016 as RBX states says -
......"Dr Kelly commenced experimental chemotherapy in early-2012 and remains in complete remission."
So that is two complete remissions is it not?
Ann: NOX Mid-Year Briefings, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $555 | 5.296K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 95000 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 151971 | 2 |
View Market Depth
| Last trade - 15.18pm 22/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
